ECSP951356A - THROMBOPOYETINE - Google Patents

THROMBOPOYETINE

Info

Publication number
ECSP951356A
ECSP951356A ECSP951356A ECSP951356A EC SP951356 A ECSP951356 A EC SP951356A EC SP951356 A ECSP951356 A EC SP951356A EC SP951356 A ECSP951356 A EC SP951356A
Authority
EC
Ecuador
Prior art keywords
tpo
isolated
thrombopoyetine
magakaryocytes
thrombopoietin
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Dan L Eaton
Souvage Frederic J De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP951356 priority Critical patent/ECSP951356A/en
Publication of ECSP951356A publication Critical patent/ECSP951356A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

El invento se refiere a la trombopoyetina aislada (tpo), dna aislado que codifica tpo, y métodos recombinantes o sintéticos de preparación y purificación de la tpo. Se muestran varias formas de tpo que influyen en la replicación, diferenciación o maduración de células sanguíneas, especialmente magacariocitos y células progenitoras megacariocitos. Consecuentemente, estos compuestos pueden ser utilizados para el tratamiento de trombocitopenia.The invention relates to isolated thrombopoietin (tpo), isolated dna encoding tpo, and recombinant or synthetic methods of preparation and purification of tpo. Various forms of tpo are shown that influence the replication, differentiation or maturation of blood cells, especially magakaryocytes and megakaryocyte progenitor cells. Consequently, these compounds can be used for the treatment of thrombocytopenia.

ECSP951356 1995-01-03 1995-01-03 THROMBOPOYETINE ECSP951356A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP951356 ECSP951356A (en) 1995-01-03 1995-01-03 THROMBOPOYETINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP951356 ECSP951356A (en) 1995-01-03 1995-01-03 THROMBOPOYETINE

Publications (1)

Publication Number Publication Date
ECSP951356A true ECSP951356A (en) 1996-02-28

Family

ID=42042000

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP951356 ECSP951356A (en) 1995-01-03 1995-01-03 THROMBOPOYETINE

Country Status (1)

Country Link
EC (1) ECSP951356A (en)

Similar Documents

Publication Publication Date Title
ES2114786A1 (en) THROMBOYETIN. RECOMBINANT THROMBOPOYETINE AND PROCEDURE FOR OBTAINING.
ES2142953T3 (en) GROWTH FACTOR AND DIFFERENTIATION OF THE TGF-BETA FAMILY.
IL114003A0 (en) Bicyclic compounds
WO1999010494A3 (en) Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
ES2126122T3 (en) NITRATE-AMINO ACID-DISULPHES FOR THE THERAPY OF DISEASES OF THE CARDIO-CIRCULATORY SYSTEM.
EE200000318A (en) Novel compounds
DK0833560T3 (en) Uniform mixtures of pesticidal granules
NO885275D0 (en) VASCULAR ANTICOAGULANT PROTEINS, DNAS WHO ENCODE THEM, MANUFACTURE AND USE THEREOF.
EA199800692A1 (en) ISOLATED MEMBERSHIPS
JPS615392B2 (en)
DE68921908D1 (en) Cell-associated glucosyltransferase, antibodies against it and a composition containing it for the prophylaxis of caries.
ECSP951356A (en) THROMBOPOYETINE
MX9604762A (en) Novel sulfonamides and process for the preparation thereof.
DK0633928T3 (en) Microorganisms, their preparation and use
UY23886A1 (en) METHODS OF PREPARING THROMBOPOYETIN
ATE376586T1 (en) PPGPP SYNTHETASE AND EXPRESSION SYSTEMS FOR IMPROVED PRODUCTION OF PROTEINS
ATE496939T1 (en) METHOD FOR PURIFYING KERATINOCYTE GROWTH FACTORS
DE59611293D1 (en) PROTEIN WITH DNASE ACTIVITY
DE59610098D1 (en) PROTEIN WITH ANTI-TUMOR EFFECT
DE3777359D1 (en) AMINO ACID SEQUENCE OF THE HUMAN ALPHA 2 PLASMIN INHIBITOR AND CDNS, AND GENOIC DNA CODING THIS AMINO ACID SEQUENCE.
DE69827808D1 (en) PROTEASE-LIKE PROTEIN
PT102695A (en) Process for preparation of oligo-saccharides with anti-ulcerative biological activity uses ligneous-cellulose materials